A phase II single-arm study of pazopanib and paclitaxel as first-line treatment for patients with advanced melanoma

被引：2
|
作者：
Fruehauf, John P.
Alger, Beverly
Jakowatz, James G.
Hsiang, David
Sender, Leonard S.
Bettis, Claudette
Casey, Cameron
机构：
[1] UCI Comprehens Canc Ctr, Orange, CA USA
[2] Univ Calif Irvine, Orange, CA 92668 USA
[3] Univ Calif Irvine, Med Ctr, Orange, CA USA
[4] UC Irvine Med Ctr, Orange, CA USA
[5] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.9036
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9036
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Updated interim analysis of UCI 09-53: A phase II, single arm study of pazopanib and paclitaxel as first-line treatment for subjects with unresectable advanced melanoma
    Ein-Gal, Shlomit Y.
    Tsang, Walter
    Alger, Beverly
    Parmakhtiar, Basmina
    Jakowatz, James G.
    Bettis, Claudette
    Fruehauf, John
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] A phase II single arm study of pazopanib and paclitaxel as first-line treatment for unresectable stage III and stage IV melanoma: Interim analysis.
    Fruehauf, John P.
    Alger, Beverly
    Parmakhtiar, Basmina
    Jakowatz, James G.
    Bettis, Claudette
    Chuang, Tony
    Ein-Gal, Shlomit Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Toripalimab plus bevacizumab as first-line treatment for advanced hepatocellular carcinoma: A single-arm phase II study
    Hao, Chunyi
    Du, Chengyou
    Peng, Baogang
    Zhang, Wu
    Shan, Yunfeng
    Lv, Ang
    Wu, Jianhui
    Shang, Changzhen
    Luo, Xuan
    Wei, Jinxing
    Xiao, Heng
    Qiu, Jianguo
    Hua, Yunpeng
    Shen, Shunli
    Wang, Ting
    Dai, Shengjie
    Chen, Xiang
    Yan, Shican
    Hao, Chunyi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [4] A Multicenter Phase I Study of Pazopanib in Combination with Paclitaxel in First-Line Treatment of Patients with Advanced Solid Tumors
    Kendra, Kari L.
    Plummer, Ruth
    Salgia, Ravi
    O'Brien, Mary E. R.
    Paul, Elaine M.
    Suttle, A. Benjamin
    Compton, Natalie
    Xu, Chun-Fang
    Ottesen, Lone H.
    Villalona-Calero, Miguel A.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (02) : 461 - 469
  • [5] Gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer: A multicenter, single-arm, phase I/II trial
    Pressiani, T.
    Balsano, R.
    Giordano, L.
    Milella, M.
    Bergamo, F.
    Bozzarelli, S.
    Noventa, S.
    Ferrari, D.
    Scartozzi, M.
    Parra, H. J. Soto
    Auriemma, A.
    Solda, C.
    Zaniboni, A.
    Zecchetto, C.
    Rizzato, M. D.
    Rimassa, L.
    Santoro, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S120 - S120
  • [6] First-Line Treatment of Locally Advanced or Metastatic Pulmonary Lymphoepitheliomalikecarcinoma: A Multicenter, Single-Arm, Phase II Trial
    Zhou, C.
    Lin, X.
    Li, S.
    Sun, N.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S96 - S97
  • [7] Efficacy and safety of camrelizumab combined with chemotherapy in the first-line treatment of advanced gastric cancer: a single-arm, phase II study
    Liu, Wenlou
    Wang, Hongmei
    Zhao, Yang
    Ge, Yan
    Tang, Juangjuang
    Cao, Menghan
    Matsas, Silvio
    Breadner, Daniel Adam
    Qin, Xiaobing
    Han, Zhengxiang
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (04)
  • [8] CAMRELIZUMAB COMBINED WITH PACLITAXEL AND NEDAPLATIN IN THE FIRST-LINE TREATMENT OF LOCALLY ADVANCED/ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A PHASE II, SINGLE-ARM, EXPLORATORY RESEARCH
    Ma, Jianqun
    Zhang, Jinfeng
    Yang, Yingnan
    Zheng, Dayong
    Wang, Xiaoyuan
    Liang, Hao
    Zhang, Luquan
    Xin, Yanzhong
    Ling, Xiaodong
    Fang, Chengyuan
    Jiang, Hao
    Zheng, Wei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A437 - A437
  • [9] Camrelizumab combined with paclitaxel and nedaplatin in the first-line treatment of locally advanced/advanced esophageal squamous cell carcinoma: A phase II, single-arm, exploratory research
    Wang, X.
    Ma, J.
    Zhang, J.
    Yang, Y.
    Zheng, D.
    Liang, H.
    Zhang, L.
    Xin, Y.
    Ling, X.
    Fang, C.
    Jiang, H.
    Zheng, W.
    ANNALS OF ONCOLOGY, 2021, 32 : S1400 - S1400
  • [10] A Single-Arm Phase II Study of Anlotinib Combined with Pemetrexed plus Cisplatin as a First-Line Therapy in Advanced NSCLC
    Xiong, J.
    Li, J.
    Deng, J.
    Zhang, W.
    Wang, H.
    Zeng, L.
    Shi, H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S675 - S676
12345